178 related articles for article (PubMed ID: 24887452)
21. Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis.
Uzawa A; Mori M; Hayakawa S; Masuda S; Kuwabara S
Eur J Neurol; 2010 May; 17(5):672-6. PubMed ID: 20039942
[TBL] [Abstract][Full Text] [Related]
22. [AQP4 immunohistochemistry in neuromyelitis optica and multiple sclerosis: a neuropathological review].
Yoshida M
Brain Nerve; 2010 Sep; 62(9):961-74. PubMed ID: 20844307
[TBL] [Abstract][Full Text] [Related]
23. Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody.
Fan M; Fu Y; Su L; Shen Y; Wood K; Yang L; Liu Y; Shi FD
Mult Scler Relat Disord; 2017 Apr; 13():58-66. PubMed ID: 28427704
[TBL] [Abstract][Full Text] [Related]
24. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
[TBL] [Abstract][Full Text] [Related]
25. Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis.
Feng X; Reder NP; Yanamandala M; Hill A; Franek BS; Niewold TB; Reder AT; Javed A
J Neurol Sci; 2012 Feb; 313(1-2):48-53. PubMed ID: 22036215
[TBL] [Abstract][Full Text] [Related]
26. IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum.
Shimizu J; Hatanaka Y; Hasegawa M; Iwata A; Sugimoto I; Date H; Goto J; Shimizu T; Takatsu M; Sakurai Y; Nakase H; Uesaka Y; Hashida H; Hashimoto K; Komiya T; Tsuji S
Neurology; 2010 Oct; 75(16):1423-7. PubMed ID: 20826711
[TBL] [Abstract][Full Text] [Related]
27. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
Wegner C
Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
[TBL] [Abstract][Full Text] [Related]
28. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report.
Misu T; Fujihara K; Nakamura M; Murakami K; Endo M; Konno H; Itoyama Y
Tohoku J Exp Med; 2006 Jul; 209(3):269-75. PubMed ID: 16778375
[TBL] [Abstract][Full Text] [Related]
29. Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis.
Klawiter EC; Xu J; Naismith RT; Benzinger TL; Shimony JS; Lancia S; Snyder AZ; Trinkaus K; Song SK; Cross AH
Mult Scler; 2012 Sep; 18(9):1259-68. PubMed ID: 22354742
[TBL] [Abstract][Full Text] [Related]
30. Seroprevalence of NMO-IgG among patients with neuromyelitis optica and opticospinal multiple sclerosis.
Etemadifar M; Mollabashi M; Chitsaz A; Behnamfar O; Bahrami E; Minagar A; Maghzi AH
Clin Neurol Neurosurg; 2012 Jan; 114(1):17-20. PubMed ID: 22014378
[TBL] [Abstract][Full Text] [Related]
31. Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica.
Kawachi I; Nishizawa M
Neuropathology; 2015 Oct; 35(5):481-6. PubMed ID: 26079808
[TBL] [Abstract][Full Text] [Related]
32. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
33. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
Misu T; Takahashi T; Nakashima I; Fujihara K; Itoyama Y
Rinsho Byori; 2009 Mar; 57(3):262-70. PubMed ID: 19363997
[TBL] [Abstract][Full Text] [Related]
34. Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.
Oji S; Nicolussi EM; Kaufmann N; Zeka B; Schanda K; Fujihara K; Illes Z; Dahle C; Reindl M; Lassmann H; Bradl M
PLoS One; 2016; 11(3):e0151244. PubMed ID: 26990978
[TBL] [Abstract][Full Text] [Related]
35. The cervical spinal cord in neuromyelitis optica patients: a comparative study with multiple sclerosis using diffusion tensor imaging.
Pessôa FM; Lopes FC; Costa JV; Leon SV; Domingues RC; Gasparetto EL
Eur J Radiol; 2012 Oct; 81(10):2697-701. PubMed ID: 22192780
[TBL] [Abstract][Full Text] [Related]
36. Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms.
Zhang H; Bennett JL; Verkman AS
Ann Neurol; 2011 Dec; 70(6):943-54. PubMed ID: 22069219
[TBL] [Abstract][Full Text] [Related]
37. Imbalance in multiple sclerosis and neuromyelitis optica: association with deep sensation disturbance.
Demura Y; Kinoshita M; Fukuda O; Nose S; Nakano H; Juzu A; Murase N; Yamamoto K
Neurol Sci; 2016 Dec; 37(12):1961-1968. PubMed ID: 27576580
[TBL] [Abstract][Full Text] [Related]
38. Relationship between neuromyelitis optica-IgG status and spinal cord magnetic resonance imaging in patients with neuromyelitis optica.
Zhong XN; Wang HH; Bao J; Li R; Long YM; Lu ZQ; Dai YQ; Qiu W; Hu XQ
Chin Med J (Engl); 2012 Jan; 125(2):270-4. PubMed ID: 22340558
[TBL] [Abstract][Full Text] [Related]
39. Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica.
Wang KC; Tsai CP; Lee CL; Chen SY; Chin LT; Chen SJ
Neuroscience; 2012 Dec; 226():510-6. PubMed ID: 23122444
[TBL] [Abstract][Full Text] [Related]
40. Association of neuromyelitis optica with severe and intractable pain.
Qian P; Lancia S; Alvarez E; Klawiter EC; Cross AH; Naismith RT
Arch Neurol; 2012 Nov; 69(11):1482-7. PubMed ID: 22926050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
